Endourology and Stone Disease

92 Urology Journal    Vol 6    No 2    Spring 2009

Prevention of Bradycardia by Atropine Sulfate 
During Urological Laparoscopic Surgery
A Randomized Controlled Trial 

Homayun Aghamohammadi,1 Sadrollah Mehrabi,2 Faramarz Mohammad Ali Beigi3

Introduction: Cardiac arrhythmias are a well-recognized complication of 
anesthesia for laparoscopy. The aim of this study was to evaluate the efficacy 
of atropine sulfate for prevention of bradyarrhythmia during laparoscopic 
surgery. 
Materials and Methods: Sixty-four candidates for urological laparoscopic 
surgery were randomly assigned into 2 groups to receive either atropine 
sulfate or hypertonic saline solution (as placebo), intravenously 3 minutes 
before induction of anesthesia for the laparoscopic procedure. Then, all 
of the patients underwent anesthesia intravenous sodium thiopental and 
atracurium, followed by isoflurane or halothane inhalation. Heart rate 
and blood pressure were recorded preoperatively in the recovery room, 
preoperatively in the operation room, after induction of anesthesia, after 
induction of pneumoperitoneum, and postoperatively.
Results: A significant decreasing trend was seen in the heart rates during the 
operation in patients without atropine sulfate. Nine of 32 patients (28.1%) in 
this group developed bradycardia, while none of the patients with atropine 
sulfate prophylaxis had bradycardia perioperatively (P < .001). The mean 
decreases in systolic blood pressure between induction of anesthesia and 
pneumoperitoneum were 15.7 ± 10.2 mm Hg in group 1 and 23.5 ± 9.8 mm 
Hg in group 2 (P < .001). The mean decreases in diastolic blood pressure 
between these two measurements were 8.7 ± 5.2 mm Hg in group 1 compared 
to 12.1 ± 6.2 mm Hg in group 2 (P = .001).
Conclusion: This study suggests that routine prophylaxis with an 
anticholinergic agent might be helpful in prevention of sinus bradycardia 
during urological laparoscopic surgery.

Urol J. 2009;6:92-5. 
www.uj.unrc.ir

Keywords: urologic diseases, 
laparoscopy, bradycardia, atropine, 

cholinergic antagonists

1Department of Anesthesiology, 
Shahid Labbafinejad Medical 

Center, Shahid Beheshti University 
(MC), Tehran, Iran

2Department of Urology, Yasuj 
University of Medical Sciences, 

Yasuj, Iran
3Department of Urology, 

Shahrekord University of Medical 
Sciences, Shahrekord, Iran

Corresponding Author:
Sadrollah Mehrabi, MD

Department of Urology, Shahid 
Beheshti Hospital, Yasuj, Iran

Tel: +98 741 333 7250
Fax: +98 741 333 7250 

E-mail: mehrabi390@yahoo.com

Received September 2008
Accepted December 2008

INTRODUCTION
Laparoscopic surgery is growing 
in popularity, and laparoscopic 
procedures are being done in a 
broad population of patients. As 
a result, we can anticipate more 
cases of cardiac arrhythmias, 
which are a well-recognized 
complication of anesthesia for 
laparoscopy.(1) Conditions leading 
to development of arrhythmias are 

CO2 insufflations, hypercapnea, 
increased vagal tone owing to 
traction on the pelvic or peritoneal 
structures, Trendelenburg position, 
anesthetic drugs (especially, 
halothane in combination 
with spontaneous ventilation), 
preoperative patient’s anxiety, 
endobronchial intubation, and gas 
embolism.(1,2)



Bradycardia During Laparoscopic Surgery—Aghamohammadi et al

Urology Journal    Vol 6    No 2    Spring 2009 93

Anesthesiologist should be aware of the risk 
of cardiac arrhythmias and of the problems 
inherent to the pneumoperitoneum during 
laparoscopy. Excessive vagal activity which 
causes severe bradycardia and hypotension 
can be life threatening.(2) Prompt treatment 
is needed with the use of anticholinergic and 
sympathomimetic drugs.(3,4) There are studies 
addressing administration of anticholinergic 
agents, especially glycopyrrolate and atropine, 
for prevention of bradycardia during open 
surgeries in children and adults.(3-6) Such studies 
have also been done for gynecologic laparoscopic 
surgeries(7); however, there are limited data on 
the efficacy of these drugs during urological 
laparoscopic surgeries. The aim of this study is 
to evaluate the efficacy of atropine sulfate for 
prevention of bradyarrhythmia during urological 
laparoscopic operations.

MATERIALS AND METHODS
In a randomized double-blinded placebo-
controlled trial, we enrolled patients who were 
candidates for elective urological laparoscopic 
surgical operation. After obtaining informed 
consent and approval of the study by ethics 
committee of our university, we selected patients 
aged between 15 and 50 years old who were 
candidates for elective urological laparoscopic 
surgery. All of the patients were in the American 
Society of Anesthesiologists’ categories I and II 
and did not have any history of cardiac disease. 
The exclusion criteria were history of cardiac 
arrhythmias (such as sick sinus syndrome), 
drug-induced bradycardia, and cardiac disease, 
as well as contraindication of general anesthesia 
or laparoscopic surgery. A total of 64 eligible 
patients were selected and were randomly 
assigned into 2 groups by simple randomization 
method. 

In group 1, atropine sulfate, 0.6 mg, and fentanyl, 
100 μg, were administered intravenously 
immediately before induction of anesthesia 
for the laparoscopic procedure. In group 2 
(control), hypertonic saline solution, dispensed 
in similar bottles to atropine sulfate bottles, 
was administered intravenously along with 
fentanyl, before induction of anesthesia. 

Then, all of the patients underwent a balanced 
anesthesia, including induction of anesthesia 
with intravenous sodium thiopental, 5 mg/kg 
to 6 mg/kg, followed by atracurium, 0.5 mg/
kg. After endotracheal intubation, maintenance 
of anesthesia was continued by inhalational 
anesthetic drugs (isoflurane or halothane) and 
positive pressure ventilation.

The patients were secured slightly head down in 
the supine or semilateral position, and their intra-
abdominal pressure was maintained below 15 mm 
Hg during the operation. They were monitored 
with a noninvasive arterial pressure measurement 
device, electrocardiography, pulse oximetry, and 
capnography. Controlled ventilation was used 
throughout to maintain eucapnia. Heart rate 
and blood pressure were recorded as following 
in all of the patients: (1) preoperatively in 
the recovery room, (2) preoperatively in the 
operation room, (3) after induction of anesthesia, 
(4) after induction of pneumoperitoneum, and 
(5) postoperatively. If arrhythmia or bradycardia 
developed, it would be controlled by atropine 
sulfate or other anti-arrhythmic drugs.

The collected data were analyzed using the 
SPSS software (Statistical Package for the Social 
Sciences, version 11.5, SPSS Inc, Chicago, Illinois, 
USA). The t test was used to compare the age, 
heart rate, and blood pressure variables, and 
the chi-square test, to compare the frequency of 
bradycardia between the two groups. 

RESULTS
All of the patients completed the study. The 
mean age of them were 24.4 ± 7.8 years and 
20.8 ± 8.5 years in groups 1 and 2, respectively 
(P = .06). There were no significant differences 
in sex distribution between the participants in 
groups 1 and 2 (P = .27). The mean heart rates 
were not significantly different between the two 
groups preoperatively; however, a significant 
decreasing trend was seen in the heart rates during 
the operation in group 2, but not in group 1 
with atropine sulfate (Table). Nine of 32 patients 
(28.1%) in group 2 developed bradycardia (heart 
rate < 60/min), while none of the patients in 
group 1 had bradycardia perioperatively  
(P < .001). 



Bradycardia During Laparoscopic Surgery—Aghamohammadi et al

94 Urology Journal    Vol 6    No 2    Spring 2009

There were significant differences in the mean 
systolic and diastolic blood pressures after 
induction of pneumoperitoneum between groups 
1 and 2 (P = .01 and P < .001, respectively). The 
mean decreases in systolic blood pressure between 
induction of anesthesia and pneumoperitoneum 
were 15.7 ± 10.2 mm Hg in group 1 and 23.5 
± 9.8 mm Hg in group 2 (P < .001). The mean 
decreases in diastolic blood pressure between 
these two measurements were 8.7 ± 5.2 mm Hg 
in group 1 compared to 12.1 ± 6.2 mm Hg in 
group 2 (P = .001).

DISCUSSION
During anesthesia, changes in heart rate may 
suggest alterations in the depth of anesthesia, 
vagal activity, CO2 pressure, and the effects of 
drugs. Simple vagal reactions, for instance, are 
usually improved when the stimulus is stopped.(2,3) 
Cardiac arrhythmias are frequently seen during 
anesthesia in laparoscopic procedures, the most 
common of which is sinus tachycardia.(3)  
Bradyarrhythmias (eg, atroventricular 
dissociation, nodal rhythm, sinus bradycardia) 
may develop independently or in combination 
with tachycardia during the same procedure.(1,3)  
In rare cases, asystolic cardiac arrest and 
cardiovascular collapse may develop.(5) 

The present study revealed prophylactic effect 
of intravenous atropine sulfate on cardiac 
arrhythmias (sinus bradycardia) during 
anesthesia with halothane for laparoscopic 
urological surgeries in adults. Anticholinergic 
agents alter the balance between sympathetic 
and parasympathetic activity in the autonomic 
nervous system by blocking the parasympathetic 
muscarinic receptors.(6,7) In a study by Annila and 
colleagues that evaluated intravenous atropine 
sulfate and glycopyrrolate on cardiac arrhythmias 

for adenoidectomy in children, the use of 
anticholinergics did not influence the incidence 
of ventricular arrhythmias during anesthesia 
with halothane in children. Bradycardia was 
more common in the placebo group than in 
the atropine group.(3) Although patients were 
young and the procedure was not laparoscopic, 
bradycardia was more common in the placebo 
group, which is similar to our results. 

Adult sympathetic predominance may cause 
arrhythmias.(5,7) Furthermore, suppressing 
vagal activity is an important protector against 
sudden cardiac death.(5) Our results does not 
support the suggestion that anticholinergics are 
arrhytmogenic. Bradycardia was more common 
in adults receiving no medication before the 
procedure than in those who received atropine 
sulfate. However, even in those with no atropine, 
the events were short and resolved after treatment 
with atropine or spontaneously after desufflation 
or cessation of painful stimulants. 

During laparoscopic surgery, the head-up position 
and high insufflator pressure reduce venous return 
and cardiac output with a decrease in the mean 
arterial pressure and cardiac index. Conversely, 
the head-down position increases venous return 
and normalizes blood pressure.(8) In our study, 
the patient’s position was head-down and CO2 
pressure was below 15 mm Hg. Therefore, only 
during the postinduction period, there was a 
significant decrease in blood pressure between the 
two groups that could be due to the protecting 
effect of atropine againts bradycardia. 

Sinus tachycardia occurred in none of our 
patients. Heart rate tended to be higher during 
the operation, especially pneumoperitoneum 
induction; however, there was no significant 
difference in heart rate between the two 

Mean Heart Rate, /min
Time Group 1 Group 2 P

In recovery 88.4 ± 10.6 90.7 ± 13.7 .45
Preoperation 94.1 ± 9.4 98.1 ± 12.9 .05
Induction of anesthesia 101.6 ± 12.2 89.1 ± 6.4 .001
Induction of pneumoperitoneum 107.6 ± 6.1 69.4 ± 15.7 < .001
Postoperation 104.6 ± 10.8 105.8 ± 5.8 .56

Heart Rate at Different Times in Relation to Laparoscopic Surgical Operation in Patients with Atropine Sulfate (group 1) and without It 
(group 2)



Bradycardia During Laparoscopic Surgery—Aghamohammadi et al

Urology Journal    Vol 6    No 2    Spring 2009 95

groups postoperatively and in recovery room. 
Hypercarbia, hypoxia, and type of the surgical 
operation affect the incidence of cardiac 
arrhythmias. These parameters were similar in 
our groups of patients, and there were no case of 
hypoxia or hypercarbia. Bradycardia events were 
short and resolved spontaneously in atropine 
group or were treated with atropine sulfate. In 
conclusion although the use of new drugs such 
as propofol and isoflurane decreases the rate of 
cardiac complications, continuous monitoring 
of cardiovascular and pulmonary parameters is 
essential.

CONCLUSION
This study suggests that prophylactic treatment 
with cholinergic antagonists such as atropine 
sulfate can be helpful in prevention of sinus 
bradycardia during laparoscopic surgeries.

CONFLICT OF INTEREST
None declared.

REFERENCES
1. Myles PS. Bradyarrhythmias and laparoscopy: 

a prospective study of heart rate changes with 

laparoscopy. Aust N Z J Obstet gynaecol. 
1991;31:171-3.

2. Hirvonen EA, Poikolainen EO, Paakkonen 
ME, Nuutinen LS. The adverse hemodynamic 
effects of anesthesia, head-up tilt, and carbon 
dioxide pneumoperitoneum during laparoscopic 
cholecystectomy. Surg Endosc. 2000;14:272-7.

3. Annila P, Rorarius M, Reinikainen P, Oikkonen M, Baer 
g. Effect of pre-treatment with intravenous atropine 
or glycopyrrolate on cardiac arrhythmias during 
halothane anaesthesia for adenoidectomy in children. 
Br J Anaesth. 1998;80:756-60.

4. Burns JM, Hart DM, Hughes RL, Kelman Aw, 
Hillis wS. Effects of nadolol on arrhythmias during 
laparoscopy performed under general anaesthesia. Br 
J Anaesth. 1988;61:345-6.

5. Shifren JL, Adlestein L, Finkler NJ. Asystolic cardiac 
arrest: a rare complication of laparoscopy. Obstet 
gynecol. 1992;79:840-1.

6. Desalu I, Kushimo OT, Bode CO. A comparative 
study of the haemodynamic effects of atropine and 
glycopyrrolate at induction of anaesthesia in children. 
west Afr J Med. 2005;24:115-9.

7. Ambrose C, Buggy D, Farragher R, Troy A, McNulty 
C, Carey M. Pre-emptive glycopyrrolate 0.2 mg and 
bradycardia during gynaecological laparoscopy with 
mivacurium. Eur J Anaesthesiol. 1998;15:710-3.

8. gerges FJ, Kanazi gE, Jabbour-Khoury SI. 
Anesthesia for laparoscopy: a review. J Clin Anesth. 
2006;18:67-78.